|
Volumn 29, Issue 3, 2007, Pages 228-231
|
A randomized trial of irinotecan plus fuorouracil and leucovorin with thalidomide versus without thalidomide in the treatment for advanced colorectal cancer
a a a a a a
a
CANCER HOSPITAL
(China)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
DRUG DERIVATIVE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
THALIDOMIDE;
ADENOCARCINOMA;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
COLORECTAL TUMOR;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DISEASE COURSE;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
SURVIVAL;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADOLESCENT;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLORECTAL NEOPLASMS;
DIARRHEA;
DISEASE PROGRESSION;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
REMISSION INDUCTION;
SURVIVAL ANALYSIS;
THALIDOMIDE;
TREATMENT OUTCOME;
|
EID: 39849091233
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|